Mikastar 500mg Injection

Mikastar 500mg Injection Contains Amikacin is a type of antibiotic belonging to the aminoglycoside group. It is mainly used for severe bacterial infections, especially by Gram-negative bacteria.

Uses of Mikastar 500mg Injection:

• Bacterial Infection

How does Mikastar 500mg Injection work?

Mikastar 500mg Injection is an antibiotic. It works by stopping the formation of bacterial proteins. It binds to the bacterial 30S ribosomal subunit and inhibits the production of vital proteins and this results in the death of the bacterial cell. It is effective against a large number of germs owing to its bactericidal action.

How to Use & Dosage

Amikacin injection is a liquid that is given intravenously (into a vein) or intramuscularly (into a muscle) every eight to twelve hours (two to three times a day). When given intravenously it is generally infused (given slowly) over a period of 30 to 60 minutes. The length of your therapy depends on the type of infection you have.

Amikacin may be given to you in a hospital or at home. If you will be receiving amikacin injection at home, your healthcare practitioner will teach you how to use it. Carefully read these directions. If you have any questions, ask your healthcare practitioner.

Possible Side Effects:

• Injection site reactions (pain, swelling, redness)
• Nausea or vomiting
• Diarrhoea
• Skin rashes
• Hearing loss
• Balance issues

Safety Advise:

🫁 Lungs

Mikastar Injection is not known to cause harm to people with lung problems. Consult your healthcare provider.

🫀 Liver

Mikastar Injection may not be safe for people with liver problems. Please consult your healthcare provider.

🩺 Kidney

It is not known if Mikastar Injection is safe to use in people with kidney problems. Please discuss with your healthcare provider.

🤰 Pregnancy

Use Mikastar during pregnancy only if clearly needed. Talk to your doctor.

🤱 Breast-Feeding

The use of Mikastar while nursing is likely unsafe. Please consult your physician.

Storage Instructions

Keep the temperature below 25°C. Don’t freeze up. Keep out of children’s reach.

References

1. Ramirez MS, Tolmasky ME. Amikacin: uses, resistance, and prospects for inhibition. Molecules. 2017 Dec 19;22(12):2267.
2. Kawaguchi H. Discovery, chemistry, and activity of amikacin. Journal of Infectious Diseases. 1976 Nov 1;134(Supplement_2): S242-8.
3. Black RE, Lau WK, Weinstein RJ, Young LS, Hewitt WL. Ototoxicity of amikacin. Antimicrobial agents and chemotherapy. 1976 Jun;9(6):956-61.
4. Bodey GP, Valdivieso M, Feld R, Rodriguez V. Pharmacology of amikacin in humans. Antimicrobial agents and chemotherapy. 1974 May;5(5):508-12.

Disclaimer:

IHS Enterprises’s primary objective is to guarantee the accuracy, reliability, and specialist review of the information it provides to customers. The contents and information provided on this website are for informational purposes only. They should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician for guidance and any questions you may have about any condition or medication. If you do read anything from IHS Enterprises, please do not discount or delay in seeking competent medical advice. We want to enhance the doctor-patient relationship, not substitute it.

Manufacturer details

Name: Mankind Pharma Ltd

Address: 208, Okhla Industrial Estate, Phase III, New Delhi – 110020

Country of origin: India